We showed that ACBD3 expression was almost doubled in breast cancer compared to healthy tissue but that changes in expression were not related to increased copy number or changes in methylation patterns, suggesting that other mechanisms were responsible for ACBD3 over-expression. The gene discussed is ACBD3; the disease is breast cancer.